• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种测定缓释制剂体内药物释放速率常数的方法。

A method of determining the in vivo drug release rate constant of sustained-release preparation.

作者信息

Sun H, Chow M S

机构信息

Drug Information Center, Hartford Hospital, CT, USA.

出版信息

Drug Metab Dispos. 1995 Apr;23(4):449-54.

PMID:7600910
Abstract

Assuming a one-compartment model and first-order processes for drug release, absorption, and elimination, a new equation to describe the fraction of drug to be absorbed (1-Ft) for a sustained-release product is derived. Based on this equation, when In(1-Ft) vs. time is plotted, the slopes yield the drug release rate constant (Kr), the drug absorption rate constant (Ka), and two intercepts that are a mixed function of Ka, Kr, and the fraction of sustained-release (Fs). The accuracy of this equation to generate pharmacokinetic parameters, such as Ka, Kr, Fs, and the bioavailability-volume of distribution ratio (FD/V) was tested by fitting this equation to multiple simulated plasma concentration-time data (5 sets errorless and 75 sets errant data). The absolute percentage error of Ka and FD/V estimated by this equation is much less than that of traditional polyexponential equation, whereas the absolute percentage error of Kr estimated by this equation is statistically significantly less than that of traditional polyexponential equation. Furthermore, with this equation, it is easier to estimate Fs than with traditional equation. An application of this equation in generating these parameters is illustrated for a quinidine sustained-release dosage form-quinidex.

摘要

假设采用单室模型以及药物释放、吸收和消除的一级过程,推导出了一个用于描述缓释产品中药物吸收分数(1 - Ft)的新方程。基于此方程,当绘制ln(1 - Ft)对时间的曲线时,斜率可得出药物释放速率常数(Kr)、药物吸收速率常数(Ka)以及两个截距,这两个截距是Ka、Kr和缓释分数(Fs)的混合函数。通过将该方程拟合到多个模拟的血浆浓度 - 时间数据(5组无误差数据和75组有误差数据),测试了该方程生成药代动力学参数(如Ka、Kr、Fs以及生物利用度 - 分布容积比(FD/V))的准确性。该方程估计的Ka和FD/V的绝对百分比误差远小于传统的多指数方程,而该方程估计的Kr的绝对百分比误差在统计学上显著小于传统的多指数方程。此外,使用该方程比使用传统方程更容易估计Fs。以奎尼丁缓释剂型 - 硫酸奎尼丁为例说明了该方程在生成这些参数方面的应用。

相似文献

1
A method of determining the in vivo drug release rate constant of sustained-release preparation.一种测定缓释制剂体内药物释放速率常数的方法。
Drug Metab Dispos. 1995 Apr;23(4):449-54.
2
The time to reach steady state after the administration of intravenous bolus, constant infusion, and oral immediate-release and sustained-release preparations.静脉推注、持续输注、口服速释和缓释制剂给药后达到稳态的时间。
Pharmacotherapy. 1990;10(6):400-5.
3
Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.多次服用缓释制剂后卡马西平和卡马西平-环氧化物药代动力学的再分析
J Pharm Pharm Sci. 2002 May-Aug;5(2):169-75.
4
Drug absorption: a practical method to estimate the absorption rate constant.药物吸收:一种估算吸收速率常数的实用方法。
Res Commun Chem Pathol Pharmacol. 1981 Nov;34(2):217-29.
5
Predicting plasma procainamide concentrations resulting from a sustained-release preparation.预测缓释制剂产生的血浆普鲁卡因酰胺浓度。
Clin Pharm. 1985 Mar-Apr;4(2):186-91.
6
Unique approach for calculation of absorption rate constant.计算吸收速率常数的独特方法。
Res Commun Chem Pathol Pharmacol. 1977 Nov;18(3):467-75.
7
[Computer simulation of blood level profiles. Drug liberation from two sustained-release preparations and computer simulation of single- and multiple-dose pharmacokinetics].[血药浓度曲线的计算机模拟。两种缓释制剂的药物释放及单剂量和多剂量药代动力学的计算机模拟]
Pharmazie. 1992 Jul;47(7):547-52.
8
The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.二室开放身体模型中半衰期(t1/2)与平均驻留时间(MRT)之间的关系。
Biopharm Drug Dispos. 2004 May;25(4):157-62. doi: 10.1002/bdd.396.
9
Improved rearrangement of the integrated Michaelis-Menten equation for calculating in vivo kinetics of transport and metabolism.用于计算体内转运和代谢动力学的整合米氏方程的改进重排。
J Dairy Sci. 1992 Dec;75(12):3455-64. doi: 10.3168/jds.S0022-0302(92)78121-1.
10
Application of non parametric methods to pharmacokinetic models of the Michaelis-Menten type.
Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:497-500.

引用本文的文献

1
Adaptive in vivo device for theranostics of inflammation: Real-time monitoring of interferon-γ and aspirin.用于炎症治疗学的自适应体内设备:干扰素-γ和阿司匹林的实时监测。
Acta Biomater. 2020 Jan 1;101:372-383. doi: 10.1016/j.actbio.2019.10.021. Epub 2019 Oct 15.